Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Agilent Technologies Inc.
TRADE NEWS: Agilent Technologies’ New HPLC-Chip Simplifies Analysis of Phosphopeptides in Proteomics Research
March 13th, 2009
Agilent Technologies Inc. (NYSE:A) today introduced a new HPLC-Chip that dramatically simplifies the analysis of phosphopeptides in proteomics research. The Phosphochip is used with Agilent HPLC-Chip/MS instrumentation to identify post-translational modifications (PTMs) as part of regulating biological pathways. This new HPLC-Chip was co-developed with Professor Albert J.R. Heck’s group at Utrecht University as part of the Netherlands Proteomics Centre research program. Agilent’s Phosphochip is a unique product that combines enrichment and analysis of phosphopeptides into a single-step LC/MS analysis when used with the Agilent HPLC-Chip/MS Interface and Agilent 6000...
Source: Health Business Week (2009-03-13)
|
